ZNG Medical
ZNG Medical
The global hemoglobin test kit market is projected to reach billions by 2030, driven by the rising prevalence of anemia, diabetes, and chronic kidney diseases. Modern manufacturers are shifting from laboratory-bound equipment to Point-of-Care (POCT) devices that offer lab-quality results in under 60 seconds.
Leading factories now utilize advanced Reflectance Photometry and Electrochemical Biosensors. These technologies ensure high sensitivity and specificity, critical for accurately monitoring Hb levels and HbA1c for long-term glucose management.
Top-tier manufacturers prioritize compliance with ISO 13485, CE marking, and FDA approvals. For global procurement, these certifications are the bedrock of trustworthiness and clinical reliability.
Countries Exported
Years of Expertise
Accuracy Rate
Annual Production
When sourcing high-quality hemoglobin test kits, industry leaders are evaluated based on their R&D capacity, manufacturing scale, and global support networks.
A powerhouse in specialized needles and diagnostic components since 1996. ZNG Medical excels in providing the critical injection and blood collection components that make hemoglobin testing safe and efficient.
A global leader in POCT diagnostics, known for the Afinion™ system which provides rapid HbA1c results in clinics and hospitals.
Offers the gold standard in laboratory-grade hemoglobin analysis with a focus on high-throughput screening for large medical facilities.
Pioneers in hematology analyzers, integrating hemoglobin testing into complete blood count (CBC) systems for intensive clinical use.
Focuses on digital health integration, ensuring hemoglobin data is seamlessly uploaded to Electronic Health Records (EHR).
Specializes specifically in hemoglobin and hematocrit testing, with devices like the Hemo Control used globally in blood banks.
A significant player in the home-testing market, providing affordable and reliable blood glucose and hemoglobin monitoring systems.
Renowned for precision engineering in micro-hematology analyzers, ideal for pediatric and specialized clinics.
Dominates the automated hematology market, providing the high-end infrastructure for national health screening programs.
Leading experts in the HPLC method for hemoglobin A1c testing, the preferred method for diagnosing diabetes complications.
Zhejiang ZNG Medical founded in 1996, as the leading medical device company, we are dedicated to the researching and developing and producing of injection products. Through the ISO 9001 quality system and CE product certification, we will provide secure and efficient products to market.
Needles & Components: We produce Pen needles, blood collection needles, spinal needles, dental needles, and specialized biopsy needles. Our development of special needles according to customer's drawing and request sets us apart in the global supply chain.
Mission: ZNG Medical is committed to public health needs, by listening to customers' requests and services, we can better understand the needs of customers, and this helps us to improve our existing products and develop new products.
Producing Cannula
Precision drawing of medical-grade steel.
Injection Molding
High-tech automated molding of components.
Automated Assembling
Cleanroom environment assembly line.
Sterilized by EO
Ethylene Oxide sterilization for safety.
Government health departments and large NGOs often procure hemoglobin test kits in bulk for national anemia screening programs. Key factors for these buyers include unit cost efficiency and long-term reagent stability in tropical climates.
In community clinics and rural health centers, portable hemoglobin meters are indispensable. They allow immediate diagnosis of maternal anemia, reducing the need for patients to travel to distant urban hospitals.
Sourcing from Chinese factories like ZNG Medical offers a unique blend of massive scale and rapid customization. Our ability to modify needle gauges or adapt packaging for local languages helps distributors capture market share quickly.
As we move into 2025, the integration of AI-driven diagnostics is the primary trend. Future hemoglobin test kits will not just provide a number but will analyze the data to suggest nutritional interventions or flag potential underlying conditions, connecting directly to smartphone apps for patient self-management.
